Evonetix Revenue and Competitors
Estimated Revenue & Valuation
- Evonetix's estimated annual revenue is currently $5.4M per year.
- Evonetix's estimated revenue per employee is $91,800
Employee Data
- Evonetix has 59 Employees.
- Evonetix grew their employee count by -48% last year.
Evonetix's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Research and Development | Reveal Email/Phone |
2 | VP Product | Reveal Email/Phone |
3 | Head Production and Test | Reveal Email/Phone |
4 | VP Human Resources | Reveal Email/Phone |
5 | VP Science and Applications | Reveal Email/Phone |
6 | Head DNA Synthesis | Reveal Email/Phone |
7 | Head Biology | Reveal Email/Phone |
8 | VP Finance | Reveal Email/Phone |
9 | Founder and Chief Technology Officer | Reveal Email/Phone |
10 | Marketing Communications Manager | Reveal Email/Phone |
Evonetix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $50.8M | 328 | 3% | N/A | N/A |
What Is Evonetix?
We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible.
keywords:N/AN/A
Total Funding
59
Number of Employees
$5.4M
Revenue (est)
-48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Evonetix News
Evonetix, a synthetic biology company, announced that it had been granted patent EP3551331B1 in Europe for its proprietary thermal control...
Evonetix, a Cambridge-based synthetic biology company, has won a significant patent approval in Europe. It covers the company's proprietary...
CAMBRIDGE, England--(BUSINESS WIRE)--EVONETIX LTD ('Evonetix'), the synthetic biology company bringing semiconductor technology to DNA...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.4M | 59 | 23% | N/A |
#2 | $9.1M | 59 | 51% | N/A |
#3 | $9.1M | 59 | 51% | N/A |
#4 | $7.4M | 59 | 0% | N/A |
#5 | N/A | 59 | 9% | N/A |